US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

1.97

+0.01010.52%

Volume:67.85K

Turnover:132.29K

Market Cap:60.80M

PE:-4.75

High:2.00

Open:1.94

Low:1.90

Close:1.96

Loading ...

Overview Company News Filings

Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Restoring Mitochondrial Function Without Inducing Cell Proliferation

Telomir Pharmaceuticals Raises $2.9 Million in Stock Sale

Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today?

BUZZ-U.S. STOCKS ON THE MOVE-Independent Bank, Invesco

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Eos Energy, Norfolk Southern, Coinbase

Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday

MT Newswires Live

Telomir says data show Telomir-1 reversed epigenetic silencing

Telomir Pharmaceuticals Reveals Promising Preclinical Cancer Results

Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Reversing Gene Silencing in Prostate Cancer Models

Telomir Pharmaceuticals Reports Positive Preclinical Data

Telomir Pharmaceuticals Reveals Promising Preclinical Data for Telomir-1 in Combatting Rapid Aging in Progeria Patients

Telomir Pharmaceuticals Announces Promising Preclinical Results

Telomir Pharmaceuticals Unveils Promising Preclinical Results for Telomir-1 in Treating Wilson's Disease

Telomir Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership: Alan Weichselbaum, Chief Financial Officer

Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model

Telomir Pharmaceuticals Announces Upcoming Clinical Trials for Telomir-1, Aiming to Tackle Aging and Rare Diseases

Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Treating Age-Related Macular Degeneration

BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing

Telomir Pharmaceuticals Appoints New Chief Financial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TELO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TELO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":1.9701,"timestamp":1753972543448,"preClose":1.96,"halted":0,"volume":67846,"delay":0,"floatShares":18269401,"shares":30862671,"eps":-0.414741,"marketStatus":"Trading","change":0.0101,"latestTime":"07-31 10:36:01 EDT","open":1.935,"high":2,"low":1.9,"amount":132294.3198122,"amplitude":0.05102,"askPrice":1.98,"askSize":50,"bidPrice":1.97,"bidSize":212,"shortable":3,"etf":0,"ttmEps":-0.414741,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753992000000},"marketStatusCode":2,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.96,"preHourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.96,"latestTime":"09:29 EDT","volume":7554,"amount":14653.0656378,"timestamp":1753968599999},"postHourTrading":{"tag":"盘后","latestPrice":1.9,"preClose":1.96,"latestTime":"19:59 EDT","volume":21015,"amount":41474.3856,"timestamp":1753919953329},"volumeRatio":0.290557},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","floatShares":18269401,"roa":"-391.62%","roe":"-872.57%","lyrEps":-0.559686,"volumeRatio":0.290557,"shares":30862671,"dividePrice":0,"high":2,"amplitude":0.05102,"preClose":1.96,"low":1.9,"week52Low":1.12,"pbRate":"-377.41","week52High":8.4,"institutionHeld":0,"latestPrice":1.9701,"committee":0.618321,"eps":-0.414741,"divideRate":0,"volume":67846,"delay":0,"ttmEps":-0.414741,"open":1.935,"prevYearClose":4.12,"prevWeekClose":2.19,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":2.29,"twentyDayClose":1.18,"sixtyDayClose":2.57},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TELO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553240456","title":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Restoring Mitochondrial Function Without Inducing Cell Proliferation","url":"https://stock-news.laohu8.com/highlight/detail?id=2553240456","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553240456?lang=en_us&edition=fundamental","pubTime":"2025-07-24 04:02","pubTimestamp":1753300931,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Restoring Mitochondrial Function Without Inducing Cell Proliferation. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL7x7pN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2553265463","title":"Telomir Pharmaceuticals Raises $2.9 Million in Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2553265463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553265463?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:38","pubTimestamp":1753216736,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals, Inc. ( ($TELO) ) has provided an announcement. On July 18, 2025, Telomir Pharmaceuticals, Inc. sold 1,100,000 shares of it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-raises-2-9-million-in-stock-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-raises-2-9-million-in-stock-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2552413261","title":"Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552413261","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552413261?lang=en_us&edition=fundamental","pubTime":"2025-07-19 08:46","pubTimestamp":1752885960,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals stock rocketed on Friday after the company posted positive prostate cancer treatment data.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-telomir-pharmaceuticals-stock-telo-up-150-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-telomir-pharmaceuticals-stock-telo-up-150-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2552492889","title":"BUZZ-U.S. STOCKS ON THE MOVE-Independent Bank, Invesco","url":"https://stock-news.laohu8.com/highlight/detail?id=2552492889","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552492889?lang=en_us&edition=fundamental","pubTime":"2025-07-19 01:57","pubTimestamp":1752861476,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Independent Bank, InvescoEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nL6N3TF0GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV","HES","SCHW","RIO.UK","FCX","LU0496365809.HKD","IE00BWDBJ516.SGD","AXP","SRFM","LU0094547139.USD","CVS","BLK","HUM","NSC","BKSY","IVZ","SCCO","TELO","EOSE","LU2592432038.USD","LU1988902786.USD","VTRS","BHP.AU","NEM","IE00B19Z9Z06.USD","STEM","DELL","SLB","LDI","RIO.AU","PTNM","WST","INDB","TLN","LU1778281490.HKD","EAF","MMM","IE00BN29S564.USD","IBKR","MOH","LU0211328371.USD","RF","EVH"],"gpt_icon":1},{"id":"2552425494","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2552425494","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552425494?lang=en_us&edition=fundamental","pubTime":"2025-07-19 01:42","pubTimestamp":1752860559,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  said Friday its drug candidate, Telomir-1, helped restore a tumor suppressor in human prostate cancer cells based on preclinical findings.Shares jumped about 88% as intraday trading volume surged to over 122 million from a daily average of roughly 601,000.AgEagle Aerial Systems  said its eBee TAC drone is now Blue UAS certified, making it eligible for procurement by the US Department of Defense and other federal agencies.Shares surged 31% as intraday trading volume climbed to more than 131.2 million from a daily average of about 3.19 million.MEI Pharma  said that it struck a $100 million private placement deal to start its Litecoin treasury strategy.Shares advanced 30% as trading volume soared to more than 39 million from a daily average of about 30,000.Price: 2.31, Change: +1.10, Percent Change: +90.91","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4152","UAVS","BK4139","BK4603","MEIP","TELO","LTC.USD.HKCC","BK4007","LTC.USD.CC"],"gpt_icon":0},{"id":"2552499784","title":"BUZZ-U.S. STOCKS ON THE MOVE-Eos Energy, Norfolk Southern, Coinbase","url":"https://stock-news.laohu8.com/highlight/detail?id=2552499784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552499784?lang=en_us&edition=fundamental","pubTime":"2025-07-19 00:06","pubTimestamp":1752854770,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Eos Energy, Norfolk Southern, CoinbaseEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nL6N3TF0N7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXP","PTNM","TELO","ELV","TLN","EVH","SGXZ31699556.SGD","BLK","LU1267930730.SGD","LU1599440770.SGD","BKSY","LDI","LU1917777945.USD","EAF","LU0742534661.SGD","CVS","VST","LU0234572021.USD","SLB","EOSE","HUM","SCHW","IVZ","MMM","FCX","RF","STEM","RIO.AU","MOH","LU2272731600.USD","NSC","HES","NEM","SRFM","COIN","VTRS","IBKR","CEG","BHP.AU","TDTH","SCCO","RIO.UK"],"gpt_icon":1},{"id":"2552498191","title":"Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2552498191","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552498191?lang=en_us&edition=fundamental","pubTime":"2025-07-18 21:19","pubTimestamp":1752844764,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher pre-bell Friday as the Health Care Select Sector SPDR Fund  was slightly advancing and the iShares Biotechnology ETF  was up 0.4% recently.Viatris  shares were down more than 3% after the company said a phase 3 study evaluating the efficacy and safety of MR-139 ophthalmic ointment in subjects with blepharitis did not meet its primary endpoint of complete resolution of debris after six weeks of twice daily dosing.Telomir Pharmaceuticals  shares were up more than 153% after the company said its lead candidate Telomir-1 may help restore a tumor suppressor in human prostate cancer cells.Sarepta Therapeutics  shares were down 25% following reports of another patient death in the company's gene therapy trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","LU1839511570.USD","LU2087621335.USD","BK4007","IE00BFTCPJ56.SGD","BK4581","BK4588","BK4139","IBB","IE00BJJMRZ35.SGD","VTRS","BK4583","IE0002141913.USD","IE00BJT1NW94.SGD","IE0009355771.USD","XLV","TELO","BK4585"],"gpt_icon":1},{"id":"2552432832","title":"Telomir says data show Telomir-1 reversed epigenetic silencing","url":"https://stock-news.laohu8.com/highlight/detail?id=2552432832","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552432832?lang=en_us&edition=fundamental","pubTime":"2025-07-18 06:00","pubTimestamp":1752789618,"startTime":"0","endTime":"0","summary":"In a regulatory filing, Telomir Pharmaceuticals (TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-says-data-show-telomir-1-reversed-epigenetic-silencing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-says-data-show-telomir-1-reversed-epigenetic-silencing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2552343488","title":"Telomir Pharmaceuticals Reveals Promising Preclinical Cancer Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2552343488","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552343488?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:37","pubTimestamp":1752784623,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals, Inc. ( ($TELO) ) has shared an announcement. On July 17, 2025, Telomir Pharmaceuticals announced preclinical results showi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-reveals-promising-preclinical-cancer-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-reveals-promising-preclinical-cancer-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2552431391","title":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Reversing Gene Silencing in Prostate Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431391","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552431391?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:02","pubTimestamp":1752782543,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Reversing Gene Silencing in Prostate Cancer Models. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLb2ysN9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2544990333","title":"Telomir Pharmaceuticals Reports Positive Preclinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2544990333","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544990333?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:53","pubTimestamp":1750254789,"startTime":"0","endTime":"0","summary":"An update from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On June 18, 2025, Telomir Pharmaceuticals announced positive preclinical...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-reports-positive-preclinical-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-reports-positive-preclinical-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2544701529","title":"Telomir Pharmaceuticals Reveals Promising Preclinical Data for Telomir-1 in Combatting Rapid Aging in Progeria Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2544701529","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544701529?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:15","pubTimestamp":1750252519,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc. has announced new preclinical data regarding its lead candidate, Telomir-1, which shows promising results in preventing cellular aging in human progeria cell lines. The study utilized cell lines from the Progeria Research Foundation and demonstrated that Telomir-1 targets key mechanisms of disease progression in progeria, including oxidative stress, metal toxicity, and mitochondrial instability. These findings build on previous studies in zebrafish and nematodes and suggest potential applications for Telomir-1 in treating other age-related diseases. The company plans to engage with the U.S. Food and Drug Administration to explore regulatory pathways and is evaluating multiple rare disease indications for initial clinical development. The results have been presented and indicate a significant step toward clinical translation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL2B9mtG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2542580255","title":"Telomir Pharmaceuticals Announces Promising Preclinical Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2542580255","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542580255?lang=en_us&edition=fundamental","pubTime":"2025-06-11 21:59","pubTimestamp":1749650342,"startTime":"0","endTime":"0","summary":"The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On June 11, 2025, Telomir Pharmaceuticals announced promising preclinical ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-announces-promising-preclinical-results-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-announces-promising-preclinical-results-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2542871475","title":"Telomir Pharmaceuticals Unveils Promising Preclinical Results for Telomir-1 in Treating Wilson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2542871475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542871475?lang=en_us&edition=fundamental","pubTime":"2025-06-11 21:31","pubTimestamp":1749648686,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc.  has announced promising preclinical data for its lead small molecule candidate, Telomir-1, in the treatment of Wilson's disease. The study demonstrated that Telomir-1 significantly improved neurological, behavioral, liver, and kidney functions in a genetically relevant animal model of the disease. Results showed a dose-dependent reversal of neurological dysfunction, organ damage, copper accumulation, and mortality. Additionally, Telomir-1 normalized critical liver health markers, indicating potential protection of liver function. These findings justify further development towards human clinical trials, which are planned for the first half of 2026. The company aims to submit an Investigational New Drug  application by the end of the year, advancing Telomir-1 as a potential disease-modifying treatment for rare disorders involving copper dysregulation. Results of the preclinical study were presented on June 11, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDLzbD9m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2542723316","title":"Telomir Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership: Alan Weichselbaum, Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542723316","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542723316?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:13","pubTimestamp":1749554012,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc. has filed an initial statement of beneficial ownership. The document lists Alan Weichselbaum as the beneficial owner, serving as the Chief Financial Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL8rfxTZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2541027722","title":"Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2541027722","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541027722?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:01","pubTimestamp":1749124874,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLcb9xqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2540760747","title":"Telomir Pharmaceuticals Announces Upcoming Clinical Trials for Telomir-1, Aiming to Tackle Aging and Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760747?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:01","pubTimestamp":1748865690,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc.  has announced its participation in the upcoming BIO International Convention 2025 in Boston, Massachusetts, scheduled from June 16-19, 2025. The company plans to engage in BIO One-on-One Partnering meetings to explore potential licensing, strategic collaborations, and M&A opportunities. Additionally, Telomir provided updates on its lead candidate, Telomir-1, which is designed to elongate telomeres, regenerate cells, and address key drivers of biological aging. The company is preparing for an Investigational New Drug  submission by the end of the year and anticipates initiating first-in-human clinical trials in the first half of 2026. Telomir also reported preclinical progress in areas such as retinal regeneration, lifespan extension, Type 2 diabetes reversal, and anti-cancer effects. Furthermore, Telomir is launching a rare disease development initiative targeting conditions like Werner's syndrome, Wilson's disease, Progeria, and dysphonia.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2w0B8x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2539257705","title":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Treating Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2539257705","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539257705?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:01","pubTimestamp":1748520064,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc. has announced promising preclinical results from its ongoing development of Telomir-1, an investigational oral small molecule candidate for treating age-related macular degeneration . The study utilized the Sen57wrn-/-ND6-/+ zebrafish model, which reflects key features of dry AMD and geographic atrophy observed in humans. Over a 14-day period, Telomir-1 was administered orally to 18-month-old animals. The treatment resulted in improved central vision response and motion detection, regeneration of several critical retinal layers, and a reduction in oxidative stress. Notably, untreated animals experienced a 15% mortality rate, while no mortality was observed in the Telomir-1 treated groups. These findings are considered a significant preclinical milestone that supports the continued advancement of Telomir-1 towards an Investigational New Drug  submission.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL9WDV7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2537520249","title":"BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537520249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537520249?lang=en_us&edition=fundamental","pubTime":"2025-05-22 06:42","pubTimestamp":1747867341,"startTime":"0","endTime":"0","summary":"BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC FilingTelomir Pharmaceuticals Inc TELO.O:TELOMIR PHARMACEUTICALS INC - MICHELLE YANEZ STEPS DOWN AS CFO OF TELOMIR PHARMACEUTICALS - SEC FILINGTELOMIR PHARMACEUTICALS INC - APPOINTS ALAN WEICHSELBAUM AS CFO - SEC FILINGSource text: [ID:n0001641172-25-011938]Further company coverage: TELO.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO"],"gpt_icon":0},{"id":"2537525749","title":"Telomir Pharmaceuticals Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2537525749","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537525749?lang=en_us&edition=fundamental","pubTime":"2025-05-22 05:49","pubTimestamp":1747864151,"startTime":"0","endTime":"0","summary":"The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On May 16, 2025, Telomir Pharmaceuticals, Inc. announced the mutual resign...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TELO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TELO","fiscalQuarterEnding":"2025/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-02-04","symbol":"TELO","fiscalQuarterEnding":"2024/12","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2024-11-12","symbol":"TELO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TELO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TELO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TELO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TELO","date":"2025-07-30","current":-5.078568,"percent":0.819672,"low":-83.265127,"twenty":-9.9058,"median":-7.039655,"eighty":-5.20248,"high":-2.69963,"avg":-11.571592,"sd":13.915644,"marketCap":63268475},"quantilePoints":[{"date":"2024-02-16","current":-56.39638,"twenty":-61.770129,"median":-49.049457,"eighty":-41.982417,"marketCap":238655100},{"date":"2024-02-23","current":-62.343889,"twenty":-63.029602,"median":-60.594622,"eighty":-46.922348,"marketCap":263823442},{"date":"2024-03-01","current":-63.46342,"twenty":-63.421438,"median":-62.588787,"eighty":-53.457611,"marketCap":268561012},{"date":"2024-03-08","current":-60.874505,"twenty":-63.351467,"median":-62.553802,"eighty":-58.915325,"marketCap":257605381},{"date":"2024-03-15","current":-45.550923,"twenty":-63.197532,"median":-61.749139,"eighty":-48.657621,"marketCap":192759889},{"date":"2024-03-22","current":-47.510102,"twenty":-63.029602,"median":-60.594622,"eighty":-45.928765,"marketCap":201050637},{"date":"2024-03-28","current":-35.580099,"twenty":-62.973626,"median":-56.39638,"eighty":-42.472212,"marketCap":150565904},{"date":"2024-04-05","current":-16.558518,"twenty":-62.833684,"median":-48.559663,"eighty":-36.881554,"marketCap":216450701},{"date":"2024-04-12","current":-18.574281,"twenty":-62.595784,"median":-46.390571,"eighty":-17.881143,"marketCap":242800474},{"date":"2024-04-19","current":-18.007992,"twenty":-62.469837,"median":-45.480952,"eighty":-18.234508,"marketCap":235398021},{"date":"2024-04-26","current":-15.402836,"twenty":-62.287913,"median":-41.632564,"eighty":-16.272973,"marketCap":201343774},{"date":"2024-05-03","current":-15.493668,"twenty":-61.8401,"median":-38.868721,"eighty":-15.530047,"marketCap":202531127},{"date":"2024-05-10","current":-14.814122,"twenty":-61.126399,"median":-34.985348,"eighty":-15.280653,"marketCap":193648183},{"date":"2024-05-17","current":-9.713938,"twenty":-60.762552,"median":-20.205194,"eighty":-14.460757,"marketCap":183044909},{"date":"2024-05-24","current":-9.899514,"twenty":-60.034856,"median":-18.959358,"eighty":-13.282876,"marketCap":186541828},{"date":"2024-05-31","current":-9.506677,"twenty":-58.635442,"median":-18.087272,"eighty":-12.474215,"marketCap":179139374},{"date":"2024-06-07","current":-8.846709,"twenty":-55.220872,"median":-16.988785,"eighty":-10.175947,"marketCap":166703252},{"date":"2024-06-14","current":-8.642433,"twenty":-50.224965,"median":-16.082609,"eighty":-9.764378,"marketCap":162853977},{"date":"2024-06-21","current":-8.249595,"twenty":-49.049457,"median":-15.652229,"eighty":-9.506677,"marketCap":155451523},{"date":"2024-06-28","current":-7.558201,"twenty":-48.069868,"median":-15.505107,"eighty":-8.846709,"marketCap":142423205},{"date":"2024-07-05","current":-6.803952,"twenty":-47.622055,"median":-15.431264,"eighty":-8.793283,"marketCap":128210494},{"date":"2024-07-12","current":-6.489682,"twenty":-46.614477,"median":-14.995334,"eighty":-8.611006,"marketCap":122288531},{"date":"2024-07-19","current":-5.892568,"twenty":-46.222641,"median":-14.134574,"eighty":-8.227596,"marketCap":111036802},{"date":"2024-07-26","current":-6.096844,"twenty":-45.67687,"median":-13.432376,"eighty":-7.822188,"marketCap":114886078},{"date":"2024-08-02","current":-5.248314,"twenty":-45.438969,"median":-12.639572,"eighty":-6.797667,"marketCap":98896778},{"date":"2024-08-09","current":-6.741098,"twenty":-44.067543,"median":-12.367753,"eighty":-6.690814,"marketCap":127026102},{"date":"2024-08-16","current":-6.303607,"twenty":-42.052388,"median":-10.284417,"eighty":-6.64996,"marketCap":118143157},{"date":"2024-08-23","current":-8.29422,"twenty":-40.401079,"median":-9.899514,"eighty":-6.678244,"marketCap":155451523},{"date":"2024-08-30","current":-8.278421,"twenty":-39.141606,"median":-9.736016,"eighty":-6.690814,"marketCap":155155425},{"date":"2024-09-06","current":-8.136234,"twenty":-38.861724,"median":-9.674022,"eighty":-6.712813,"marketCap":152490542},{"date":"2024-09-13","current":-9.589698,"twenty":-36.881554,"median":-9.506677,"eighty":-6.734812,"marketCap":179731570},{"date":"2024-09-20","current":-12.386034,"twenty":-35.223248,"median":-9.49882,"eighty":-6.759954,"marketCap":232140941},{"date":"2024-09-27","current":-10.774586,"twenty":-34.271647,"median":-9.637093,"eighty":-6.791381,"marketCap":201938931},{"date":"2024-10-04","current":-8.578593,"twenty":-25.750182,"median":-9.548188,"eighty":-6.888805,"marketCap":160781290},{"date":"2024-10-11","current":-8.009846,"twenty":-20.168951,"median":-9.479108,"eighty":-7.001943,"marketCap":150121756},{"date":"2024-10-18","current":-7.425301,"twenty":-19.534707,"median":-9.44751,"eighty":-7.071981,"marketCap":139166125},{"date":"2024-10-25","current":-7.01454,"twenty":-19.059025,"median":-9.384317,"eighty":-6.903527,"marketCap":131467574},{"date":"2024-11-01","current":-6.714368,"twenty":-18.728312,"median":-9.226332,"eighty":-6.834437,"marketCap":125841709},{"date":"2024-11-08","current":-6.666973,"twenty":-18.282076,"median":-8.941959,"eighty":-6.759954,"marketCap":124953415},{"date":"2024-11-15","current":-4.809979,"twenty":-18.039704,"median":-8.846709,"eighty":-6.708049,"marketCap":110444606},{"date":"2024-11-22","current":-5.467643,"twenty":-17.654627,"median":-8.799568,"eighty":-6.673736,"marketCap":125545611},{"date":"2024-11-29","current":-5.132363,"twenty":-17.074838,"median":-8.768141,"eighty":-6.632216,"marketCap":117847059},{"date":"2024-12-06","current":-8.407791,"twenty":-16.522185,"median":-8.642433,"eighty":-6.569924,"marketCap":193055987},{"date":"2024-12-13","current":-6.737953,"twenty":-16.313655,"median":-8.594391,"eighty":-6.600602,"marketCap":154713889},{"date":"2024-12-20","current":-6.712037,"twenty":-15.964821,"median":-8.461728,"eighty":-6.495967,"marketCap":154118835},{"date":"2024-12-27","current":-6.310352,"twenty":-15.760957,"median":-8.366804,"eighty":-6.403683,"marketCap":144895507},{"date":"2025-01-03","current":-5.856836,"twenty":-15.652229,"median":-8.303377,"eighty":-6.363974,"marketCap":134482072},{"date":"2025-01-10","current":-5.325574,"twenty":-15.570683,"median":-8.28632,"eighty":-6.315537,"marketCap":122283477},{"date":"2025-01-17","current":-6.077115,"twenty":-15.523297,"median":-8.249595,"eighty":-6.288654,"marketCap":139540026},{"date":"2025-01-24","current":-6.517673,"twenty":-15.50282,"median":-8.139601,"eighty":-6.28436,"marketCap":149655935},{"date":"2025-01-31","current":-6.297394,"twenty":-15.473282,"median":-8.073041,"eighty":-6.236001,"marketCap":144597981},{"date":"2025-02-07","current":-7.867,"twenty":-15.425578,"median":-8.088839,"eighty":-6.236001,"marketCap":130062872},{"date":"2025-02-14","current":-7.722981,"twenty":-15.280653,"median":-8.030693,"eighty":-6.247693,"marketCap":127681858},{"date":"2025-02-21","current":-7.038894,"twenty":-15.117652,"median":-7.97035,"eighty":-6.260979,"marketCap":116372043},{"date":"2025-02-28","current":-7.200915,"twenty":-14.922849,"median":-7.899257,"eighty":-6.280067,"marketCap":119050684},{"date":"2025-03-07","current":-7.830995,"twenty":-14.578546,"median":-7.867,"eighty":-6.294726,"marketCap":129467618},{"date":"2025-03-14","current":-8.245048,"twenty":-14.152696,"median":-7.888185,"eighty":-6.298884,"marketCap":136313033},{"date":"2025-03-21","current":-8.209043,"twenty":-13.908059,"median":-7.867,"eighty":-6.302115,"marketCap":135717779},{"date":"2025-03-28","current":-7.110904,"twenty":-13.595467,"median":-7.836063,"eighty":-6.306305,"marketCap":117562550},{"date":"2025-04-04","current":-5.27467,"twenty":-13.332709,"median":-7.821994,"eighty":-6.280067,"marketCap":87204626},{"date":"2025-04-11","current":-4.842615,"twenty":-12.988406,"median":-7.793903,"eighty":-6.226574,"marketCap":80061584},{"date":"2025-04-17","current":-4.464567,"twenty":-12.673549,"median":-7.741272,"eighty":-6.154861,"marketCap":73811424},{"date":"2025-04-25","current":-4.590583,"twenty":-12.555761,"median":-7.674628,"eighty":-6.056383,"marketCap":75894811},{"date":"2025-05-02","current":-4.662592,"twenty":-12.434833,"median":-7.63297,"eighty":-6.012327,"marketCap":77085317},{"date":"2025-05-09","current":-4.48257,"twenty":-12.382378,"median":-7.614926,"eighty":-5.935607,"marketCap":74109050},{"date":"2025-05-16","current":-5.972632,"twenty":-12.227313,"median":-7.558201,"eighty":-5.893196,"marketCap":74406677},{"date":"2025-05-23","current":-5.255916,"twenty":-11.632708,"median":-7.513523,"eighty":-5.862019,"marketCap":65477876},{"date":"2025-05-30","current":-5.017011,"twenty":-11.501318,"median":-7.475136,"eighty":-5.83092,"marketCap":62501609},{"date":"2025-06-06","current":-4.801996,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"marketCap":59822968},{"date":"2025-06-13","current":-4.778106,"twenty":-10.774586,"median":-7.421122,"eighty":-5.634716,"marketCap":59525342},{"date":"2025-06-20","current":-4.204733,"twenty":-10.62292,"median":-7.416943,"eighty":-5.48096,"marketCap":52382300},{"date":"2025-06-27","current":-4.06139,"twenty":-10.489162,"median":-7.344933,"eighty":-5.438999,"marketCap":50596540},{"date":"2025-07-03","current":-2.747411,"twenty":-10.309584,"median":-7.267316,"eighty":-5.403258,"marketCap":34227071},{"date":"2025-07-11","current":-2.795192,"twenty":-10.167924,"median":-7.19827,"eighty":-5.305212,"marketCap":34822325},{"date":"2025-07-18","current":-2.890754,"twenty":-10.119238,"median":-7.110904,"eighty":-5.252875,"marketCap":36012831},{"date":"2025-07-25","current":-5.470931,"twenty":-9.985876,"median":-7.051517,"eighty":-5.230053,"marketCap":68156516},{"date":"2025-07-30","current":-5.078568,"twenty":-9.9058,"median":-7.039655,"eighty":-5.20248,"marketCap":63268475}],"updateTime":1753972561795}}}